Search research articles
Contact Us
Filters
Showing results (1-10 of 7) with videos related to
Page
of 1
Sort By:
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen
|
August 24, 2017
[Cystic pancreatic tumors: diagnostics and new biomarkers]
A W Berger, T Seufferlein, A Kleger
Zentralblatt Fur Chirurgie
|
July 13, 2013
[Colon Polypectomy - And Then?]
A W Berger, T J Ettrich, M M Dollinger
ESMO Real World Data and Digital Oncology
|
February 6, 2026
Cancer prevalence and care disparities among individuals with intellectual disabilities: a cross-sectional pan-cancer analysis
T Sappok, M-L Rosenbusch, R Hering, et al.
BMC Cancer
|
October 25, 2019
Nal-IRI with 5-fluorouracil (5-FU) and leucovorin or gemcitabine plus cisplatin in advanced biliary tract cancer - the NIFE trial (AIO-YMO HEP-0315) an open label, non-comparative, randomized, multicenter phase II study
L Perkhofer, A W Berger, A K Beutel, et al.
Scientific Reports
|
September 15, 2019
Genotyping of circulating tumor DNA in cholangiocarcinoma reveals diagnostic and prognostic information
T J Ettrich, D Schwerdel, A Dolnik, et al.
ESMO Open
|
February 5, 2022
Prognosis and tumor biology of pancreatic cancer patients with isolated lung metastases: translational results from the German multicenter AIO-YMO-PAK-0515 study
S F Kruger, A Lohneis, A Abendroth, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 9, 2022
Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX)-a randomized phase II trial of the AIO pancreatic cancer group
T Seufferlein, W Uhl, M Kornmann, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 7) with videos related to
Sort By:
Page
of 1
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen
|
August 24, 2017
[Cystic pancreatic tumors: diagnostics and new biomarkers]
A W Berger, T Seufferlein, A Kleger
Zentralblatt Fur Chirurgie
|
July 13, 2013
[Colon Polypectomy - And Then?]
A W Berger, T J Ettrich, M M Dollinger
ESMO Real World Data and Digital Oncology
|
February 6, 2026
Cancer prevalence and care disparities among individuals with intellectual disabilities: a cross-sectional pan-cancer analysis
T Sappok, M-L Rosenbusch, R Hering, et al.
BMC Cancer
|
October 25, 2019
Nal-IRI with 5-fluorouracil (5-FU) and leucovorin or gemcitabine plus cisplatin in advanced biliary tract cancer - the NIFE trial (AIO-YMO HEP-0315) an open label, non-comparative, randomized, multicenter phase II study
L Perkhofer, A W Berger, A K Beutel, et al.
Scientific Reports
|
September 15, 2019
Genotyping of circulating tumor DNA in cholangiocarcinoma reveals diagnostic and prognostic information
T J Ettrich, D Schwerdel, A Dolnik, et al.
ESMO Open
|
February 5, 2022
Prognosis and tumor biology of pancreatic cancer patients with isolated lung metastases: translational results from the German multicenter AIO-YMO-PAK-0515 study
S F Kruger, A Lohneis, A Abendroth, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 9, 2022
Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX)-a randomized phase II trial of the AIO pancreatic cancer group
T Seufferlein, W Uhl, M Kornmann, et al.
Page
of 1